0001127602-20-000740.txt : 20200103
0001127602-20-000740.hdr.sgml : 20200103
20200103164027
ACCESSION NUMBER: 0001127602-20-000740
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200103
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dunlop A. Sinclair
CENTRAL INDEX KEY: 0001721108
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 20506184
MAIL ADDRESS:
STREET 1: C/O APELLIS PHARMACEUTICALS, INC.
STREET 2: 6400 WESTWIND WAY, SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
BUSINESS PHONE: 502-241-4114
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-01-03
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001721108
Dunlop A. Sinclair
C/O APELLIS PHARMACEUTICALS, INC
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Stock Option (Right to Buy)
30.62
2020-01-01
4
A
0
27600
30.62
A
2029-12-31
Common Stock
27600
27600
D
This option was granted on 01/01/2020. The option vests quarterly over 1 year on the last day of each quarter from grant date.
/s/ David Watson, attorney-in-fact for Sinclair Dunlop
2020-01-03